Laurion Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-28,600
Closed -$2.84M 1376
2019
Q3
$2.84M Buy
28,600
+17,600
+160% +$1.67M 0.02% 439
2019
Q2
$1.02M Sell
11,000
-77,600
-88% -$7.37M 0.01% 559
2019
Q1
$8.36M Buy
88,600
+45,200
+104% +$3.95M 0.11% 143
2018
Q4
$2.78M Sell
43,400
-148,400
-77% -$11M 0.05% 390
2018
Q3
$17.2M Buy
+191,800
New +$16.9M 0.17% 137
2018
Q1
Sell
-70,000
Closed -$7.3M 1917
2017
Q4
$7.3M Sell
70,000
-163,000
-70% -$18.4M 0.04% 419
2017
Q3
$34M Buy
233,000
+141,600
+155% +$19.3M 0.15% 117
2017
Q2
$11.9M Buy
91,400
+21,400
+31% +$2.62M 0.07% 283
2017
Q1
$8.71M Buy
+70,000
New +$8.38M 0.07% 309
2013
Q4
Sell
-187,400
Closed -$14.4M 296
2013
Q3
$14.4M Buy
+187,400
New +$13.1M 1.06% 30

Other funds holding CELG

Laurion Capital Management's CELG Position: Q4 2019 in Review

Laurion Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,055,498 shares — an estimated $204M sold.

Laurion Capital Management first reported a position in CELG in Q3 2016 and held it in 12 quarters. The position peaked at $204M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Laurion Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Laurion Capital Management sold 2,055,498 Celgene Corp shares in Q4 2019, an estimated $204M.
  • Laurion Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 12 quarters.
  • Laurion Capital Management's Celgene Corp position peaked at $204M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Laurion Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.